Nymox Pharmaceutical Corp (NASDAQ:NYMX)

1.39
Delayed Data
As of Apr 24
 -0.048 / -3.34%
Today’s Change
0.33
Today|||52-Week Range
5.75
+247.50%
Year-to-Date

Today’s Trading

Previous close1.44
Today’s open1.48
Day’s range1.37 - 1.55
Volume1,545,482
Average volume (3 months)1,374,651
Market cap$51.1M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ONTXOnconova Therapeutic...-0.05-2.09%
HEBHemispherx Biopharma...-0.01-3.15%
OGXIOncoGenex Pharmaceut...+0.04+1.86%
IMNPImmune Pharmaceutica...-0.02-1.00%
Data as of 4:00pm ET, 04/24/2015

Financials

Last reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers